Oventus Medical Share Price and Company Fundamentals
Last traded: Today at 5:58 AM
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a customized 3D-printed nylon oral appliance for OSA patients; and ExVent, an alternative for CPAP-intolerant individuals. It also develops O2Vent. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.
|Primary activities||Develops oral devices for the therapeutic treatment of breathing disorders, especially sleep apnoea.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||1 Swann Road Suite 1 PO Box 190 Indooroopilly QLD 4068 Australia|
|Phone / Fax||61 3 0053 3159 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Oventus Medical does not pay dividends.
As of May 2021, following are the company executives and directors listed on Oventus Medical.
|Dr. Christopher Patrick Hart||Co-Founder, MD, CEO & Exec. Director||873.68k|
|Mr. Daniel Parry||Chief Financial Officer||252.74k|
|Ms. Robin Randolph||Sr. VP of Sales, Marketing & Operations - North America||306.16k|
|Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICD||Company Sec.||22.02k|
|Greg Eaton||VP Sales|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Oventus Medical is 19.78M and its enterprise value is 15.58M. The enterprise value to revenue ratio of OVN is 19.95.
The OVN's stocks Beta value is 0.62 making it 38% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Oventus Medical (OVN)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Oventus Medical (ASX:OVN) Frequently Asked Questions
1. What is Oventus Medical's Stock Symbol?
Oventus Medical trades on ASX under the ticker symbol "OVN".
2. What is Oventus Medical's stock price today?
One share of OVN stock can currently be purchased for approximately $0.125.
3. How can I contact Oventus Medical?
Oventus Medical's mailing address is 1 Swann Road Suite 1 PO Box 190 Indooroopilly QLD 4068 Australia. The company can be reached via phone at 61 3 0053 3159.
4. What is Oventus Medical's official website?
The official website of Oventus Medical is http://o2vent.com.
5. Which share registry manages Oventus Medical's stock?
Oventus Medical's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.